General Dynamics‘ (NYSE: GD) information technology business unit was awarded a position on the Omnibus III contract, which is potentially worth $497 million to all awardees, according to the company.
The company said it will provide medical research support on the five-year multi-award indefinite-delivery/indefinite-quantity contract.
General Dynamics said contractors will work with the Navy’s medicine teams to address procedures for vaccine development, basic university research, clinical trials as well as the Food and Drug Administration’s investigational process for new drug application.
The company has supported Military Health System organizations for 21 years, according to Marcus Collier, senior vice president of the health and civilian solutions division for General Dynamics Information Technology.
Collier added that the contract work will support enterprise-wide research and development efforts and support military personnel and their families.
General Dynamics said contract work includes sustaining medical research efforts with materials, personnel, limited facilities, equipment and science and technology.
